Navigation Links
Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment
Date:1/6/2009

HAMILTON, Bermuda, Jan. 6 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced that it has signed an agreement with Dong-A PharmTech Co. Ltd., based in Korea, to develop and market their orally-administered udenafil product, a phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED) in the United States. Dong-A has successfully completed Phase 2 studies of the product in the United States.

Under the terms of the agreement, Warner Chilcott has exclusive U.S. rights to develop and market the product for the treatment of ED. Dong-A will receive an initial, up-front payment and may also be eligible to receive additional payments upon achievement of certain milestones.

The product was approved by the Korean Food and Drug Administration in December of 2005 for the treatment of ED in Korea under the brand name Zydena. The product was also approved in Russia in July of 2008.

About Warner Chilcott

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceuticals market. The Company is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G

Read more on http://www.wcrx.com.

Warner Chilcott's Forward Looking Statements:

This press release contains forward-looking statements, including statements concerning our product development efforts. These statements constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words "may," "might," "will," "should," "estimate," "project," "pl
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Warner Chilcott to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
2. Warner Chilcott Announces Receipt of Paragraph IV Certification Notices
3. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance
4. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2008 Financial Results
5. House Passes Historic Bill to Protect Kids From Tobacco; Senators Webb & Warner Should Cosponsor Legislation
6. Fitness and Figure Professionals Kirsten Nicewarner and Michelle Adams to Represent GNC at Vails Teva Mountain Games
7. The Oregon Clinic Extends Patient Care Services Across Metro Portland with Time Warner Telecoms Metro Ethernet Service
8. Warner Chilcott Announces Settlement of Securities Litigation
9. LodgeNet Appoints John E. Haire, Former Time Warner Executive, to Board of Directors
10. CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecoms IP VPN
11. Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...EBRECEN, Hungary, July 3 Bertalan ...published a free e-guide for medical professio...d in medicine. Medical conferences are expensive a...r interaction. This eGuide helps doctors enter a v...d meetings for free as Second Life provides opport...
(Date:7/3/2009)...rchers express hope that finding will lead to trea...ews) -- U.S. researchers say they,ve found a majo... relapsed lung cancer. , When caught early, lun...not detected until the disease is well advanced. T...mission, the disease often springs back more virul...
(Date:7/3/2009)... SHANGHAI, July 3 /PRNewswire-Asia/ -- Sundia Me...iotech R&D outsourcing company in Shanghai,C...ppointed Senior Vice,President of Chemistry Servi...rked at Neurocrine Biosciences, a drug,discovery ...ears, from a staff,scientist to Senior Director o...
(Date:7/3/2009)... Two companies and three indiv...ellence at an annual international competition des...ons. The 15,000-member SafetyXChange.org communit...n June 30, 2009 at http://www.safetyxchange.org/s...and organizations who dedicate their lives to keep...
Breaking Medicine News(10 mins):Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4
...atest study conducted to determine the effect of p...ms has now revealed that it might be due to the co...t has been known from early times that conflict am...earning problems in children, the exact mechanism ...
...lth officials in Argentina have reported an outbre...order close to Paraguay. More than 70 cattle have ...es province, //according to reports by National Se...he origin of the outbreak is yet to be identified ...
...it was drilled into us that drink to your heart’s ...y done on Boston marathon runners proves otherwise...or hyponatremia- diluted sodium levels in blood- a...eight had the condition. This condition arises whe...
... general notion that a low fat diet is a disease b...cago study on women eating less fat and more fruit...o types of cancer or heart disease. Still they wer...The drawback of the study as perceived by some exp...
Other Medicine News:Health News:Parental Conflict Can Lead to Sleep Disorders in Children 2Health News:Fat isn't all that bad: Reduction no predecessor of reduced disease 2
(Date:6/26/2009)..., N.J., June 26 Sanofi... been made aware of data associated with a retrosp...esults of these data clearly show that no definiti...ausal relationship between Lantus(R) (insulin glar...alignancies, as the authors of the study point out...
(Date:6/26/2009)...on of Inherited and New Genetic Mutations Acting T...-USNewswire/ -- More pieces in the complex autism ...y from a research team including geneticists from ...ersity of Pennsylvania School of Medicine and sev...fied 27 different genetic regions where rare copy ...
(Date:6/25/2009)...Renowned Medical Experts Slated to Attend First Na... The first national symposium desig... will be held next week in New York City when thir...alysis from their respective fields. The SUNY You...search on the health impacts that the $5 billion-a...
(Date:6/25/2009)...N.J., June 25 "Congratulations Pre...utical companies to cut prescription costs for the...rata Company, Inc. "We thought you should know tha...one the same for psoriasis sufferers of all ages."...pany, Inc., and the submission of their findings f...
Breaking Medicine Technology:Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3More Gene Mutations Linked to Autism Risk 2More Gene Mutations Linked to Autism Risk 3More Gene Mutations Linked to Autism Risk 4SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 4Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform 2Fi Med Management Inc Acquires California and Utah based Mediplete Looks Ahead to Another Year of Growth 10577 1Cold Spring Harbor Laboratory to play central role addressing key questions in plant biology 2067 1Cold Spring Harbor Laboratory to play central role addressing key questions in plant biology 2067 2Cold Spring Harbor Laboratory to play central role addressing key questions in plant biology 2067 3Government dietary guidelines unintended consequences and public policy 10573 1Government dietary guidelines unintended consequences and public policy 10573 2Government dietary guidelines unintended consequences and public policy 10573 3Genetics Researcher at Childrens Hospital Selected as Howard Hughes Medical Institute Investigator 10570 1Genetics Researcher at Childrens Hospital Selected as Howard Hughes Medical Institute Investigator 10570 2Genetics Researcher at Childrens Hospital Selected as Howard Hughes Medical Institute Investigator 10570 3
...ase III clinical trial may commence shortly, CARMI...---,Protalix BioTherapeutics, Inc. today announced...ed States Food and Drug Administration,(FDA) that ...United,States of its lead product candidate, prGCD...orm of human Glucocerebrosidase (GCD),for the tre...
... Median time to pain progression is 66.1 weeks for...the placebo arm --,Hazard ratio of 0.64 (95% CI: 0...n the relative risk of pain progression, MARTINSRI...Call/,-- PRINCETON, N.J., and BOULDER, Colo. -- GP...ced the presentation of additional,data from the d...
Other Medicine Technology:Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 2Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD 3Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 2Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 3Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 4Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 5Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 6
...ng on a strong heritage, the Alcon OcuScan RxP Oph...ard in ophthalmic ultrasound instrumentation. With...OcuScan RxP makes it simple to obtain measurements... to enhance patient care by providing high quality...
The AIM Titanium Tibial Nail System is designed to address the mechanical failures of existing implants and expand the indications for tibial interlocking nails. It is available in a full range of di
Arthroscopic instrument system for instability and SLAP fixation.
Suture Cutter, straight
Medicine Products: